Effects of interferon-tau on cattle persistently infected with bovine viral diarrhea virus

Jpn J Vet Res. 2012 Aug;60(2-3):63-70.

Abstract

In this study, the antiviral effects of bovine interferon-tau (boIFN-tau) on bovine viral diarrhea virus (BVDV) were examined in vitro and in vivo. In the in vitro experiments, the replication of cytopathic and non-cytopathic BVDV was inhibited in the bovine cells treated with boIFN-tau. The replication of BVDV was completely suppressed by boIFN-tau at a concentration higher than 10(2) U/ml. In order to examine the effect of boIFN-tau on virus propagation in cattle persistently infected (PI) with non-cytopathic BVDV, boIFN-tau was subcutaneously administered to PI cattle at 10(5) U/kg or 10(6) U/kg body weight 5 times per week for 2 weeks. No physical abnormality such as depression was observed in the cattle during the experiment. The mean BVDV titers in the serum of the PI cattle decreased slightly during the boIFN-tau administration period with the dose of 10(6) U/kg. However, the BVDV titers in the serum returned to the pre-administration level after the final boIFN-tau administration. These results suggest that boIFN-tau demonstrates an anti-BVDV effect, reducing the BVDV level in serum transiently when injected into PI cattle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology*
  • Antiviral Agents / therapeutic use
  • Bovine Virus Diarrhea-Mucosal Disease / drug therapy
  • Bovine Virus Diarrhea-Mucosal Disease / virology*
  • Cattle
  • Diarrhea Viruses, Bovine Viral / drug effects*
  • Diarrhea Viruses, Bovine Viral / growth & development
  • Diarrhea Viruses, Bovine Viral / isolation & purification
  • Female
  • Interferon Type I / pharmacology*
  • Interferon Type I / therapeutic use
  • Pregnancy Proteins / pharmacology*
  • Pregnancy Proteins / therapeutic use
  • Recombinant Proteins / pharmacology
  • Recombinant Proteins / therapeutic use
  • Viral Load / drug effects*

Substances

  • Antiviral Agents
  • Interferon Type I
  • Pregnancy Proteins
  • Recombinant Proteins
  • interferon tau